Jane Street’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Jane Street’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,731	Closed	-$122K	–	6089
2019 Q2	$122K	Buy	+12,731	New	+$234K	﹤0.01%	4813
2018 Q2	–	Sell	-677	Closed	-$42K	–	5900
2018 Q1	$42K	Buy	677 +110	+19%	+$9.66K	﹤0.01%	4683
2017 Q4	$71K	Buy	+567	New	+$72.6K	﹤0.01%	4385
2017 Q2	–	Sell	-984	Closed	-$181K	–	5089
2017 Q1	$181K	Buy	+984	New	+$110K	﹤0.01%	3892
2016 Q2	–	Sell	-1,736	Closed	-$161K	–	4806
2016 Q1	$161K	Buy	+1,736	New	+$173K	﹤0.01%	3779
2015 Q3	–	Sell	-278	Closed	-$204K	–	4369
2015 Q2	$264K	Buy	+278	New	+$227K	﹤0.01%	2959

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jane Street's TTPH Position: Q3 2019 in Review

Jane Street sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 12,731 shares — an estimated $122K sold.

Jane Street first reported a position in TTPH in Q2 2015 and held it in 6 quarters. The position peaked at $264K in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

Jane Street reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Jane Street sold 12,731 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $122K.
Jane Street first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2015 and held it in 6 quarters.
Jane Street's Tetraphase Pharmaceuticals, Inc. position peaked at $264K in Q2 2015.
26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.